[ad_1]
“Until now, there is no rational basis for ordering this Russian product, which has cheaper, more effective and more reliable vaccines in its segment,” he said Sunday.
Mr Žumadilov emphasized that there was a lot of competition in the vector vaccine segment, such as Russia’s first candidate vaccine, Sputnik V.
“There are 18 manufacturers in the world at the same time [vakcinos] Developing. These include such respected players in the international pharmaceutical market as AstraZeneca, Johnson & Johnson, and others. At the same time, AstraZeneca already has permission to distribute its vaccine in several countries, including the UK, ”he said.
Sputnik V clinical trials have been completed or are ongoing in Russia, Belarus, the United Arab Emirates, Venezuela, India, and a few other countries.
Russia boasts that Sputnik V is “the world’s first registered vaccine against COVID-19”; the supervisory authorities authorized its distribution in early August. The move was criticized by international experts, who noted that the vaccine had only been tested on a few dozen people at that time.
Meanwhile, Russian President Vladimir Putin is not vaccinating the vaccine and said last month that it has not yet been given to people his age.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
